Xylo Technologies Ltd (XYLO)
NASDAQ: XYLO · Real-Time Price · USD
4.970
-0.210 (-4.05%)
Jun 27, 2025, 9:58 AM - Market open
Xylo Technologies Market Cap
Xylo Technologies has a market cap or net worth of $6.37 million as of June 27, 2025. Its market cap has increased by 87.26% in one year.
Market Cap
6.37M
Enterprise Value
-1.17M
1-Year Change
87.26%
Ranking
Category
Stock Price
4.97
Market Cap Chart
Since August 5, 2015, Xylo Technologies's market cap has decreased from $29.00M to $6.37M, a decrease of -78.05%. That is a compound annual growth rate of -14.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 4.20M | 61.54% |
| Dec 31, 2024 | 2.60M | -51.85% |
| Dec 29, 2023 | 5.40M | -29.87% |
| Dec 30, 2022 | 7.70M | -51.27% |
| Dec 31, 2021 | 15.80M | 28.46% |
| Dec 31, 2020 | 12.30M | 86.36% |
| Dec 31, 2019 | 6.60M | 164.00% |
| Dec 31, 2018 | 2.50M | 108.33% |
| Dec 29, 2017 | 1.20M | -66.67% |
| Dec 30, 2016 | 3.60M | -79.07% |
| Dec 31, 2015 | 17.20M | -40.69% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 698.51B |
| Johnson & Johnson | 366.18B |
| AbbVie | 327.76B |
| Novo Nordisk | 313.40B |
| UnitedHealth Group | 277.24B |
| Abbott Laboratories | 240.24B |
| Novartis AG | 232.39B |
| AstraZeneca | 218.32B |